Charles Schwab Investment Management Inc Hookipa Pharma Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.59 - $1.04 $75 - $133	128 Added 0.35%	36,413 $21,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $46,081 - $544,275	36,285 New	36,285 $49,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $54,123 - $94,003	-40,694 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $8,820 - $17,640	-7,000 Reduced 14.68%	40,694 $93,000
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $91,224 - $194,300	9,959 Added 26.39%	47,694 $437,000
Q1 2021 May 17, 2021	BUY	$10.64 - $14.7 $54,732 - $75,616	5,144 Added 15.78%	37,735 $508,000
Q3 2020 Nov 13, 2020	BUY	$8.59 - $11.89 $49,822 - $68,962	5,800 Added 21.65%	32,591 $309,000
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $39,548 - $66,187	5,470 Added 25.66%	26,791 $312,000
Q4 2019 Feb 07, 2020	BUY	$6.51 - $12.23 $138,799 - $260,755	21,321 New	21,321 $261,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.